Discussing RA: Long-term safety and efficacy of upadacitinib in SELECT trials The Immune-Mediated Inflammatory Disease Forum 19:25 3 months ago 101 Далее Скачать
Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib The Immune-Mediated Inflammatory Disease Forum 18:43 5 days ago 34 Далее Скачать
axSpA Podcast: Safety and Efficacy of Upadacitinib The Immune-Mediated Inflammatory Disease Forum 26:31 1 year ago 107 Далее Скачать
Discussing Rheumatology: Upadacitinib Safety The Immune-Mediated Inflammatory Disease Forum 7:10 4 years ago 209 Далее Скачать
Jessica Ailani, MD: Long-Term Safety and Efficacy of Ubrogepant in Acute Migraine NeurologyLive 2:57 5 years ago 1 649 Далее Скачать
Discussing RA: July 2024 The Immune-Mediated Inflammatory Disease Forum 23:24 5 months ago 100 Далее Скачать
Expert commentary: The SELECT-PsA-1 and SELECT-PsA-2 trials | Alexis Ogdie Medicine Matters rheumatology 4:00 4 years ago 204 Далее Скачать
Discussing RA: February 2024 The Immune-Mediated Inflammatory Disease Forum 10:18 9 months ago 133 Далее Скачать
Discussing RA: May 2024 The Immune-Mediated Inflammatory Disease Forum 30:08 6 months ago 167 Далее Скачать
Discussing RA: April 2024 The Immune-Mediated Inflammatory Disease Forum 11:13 7 months ago 95 Далее Скачать
AxSpA Podcast: AS Associated MACE & Upadacitinib's Long Term Safety The Immune-Mediated Inflammatory Disease Forum 18:43 1 year ago 87 Далее Скачать
The encouraging results of the LINKER-MM1 trial: safety and efficacy of linvoseltamab in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:28 8 months ago 157 Далее Скачать
Discussing Rheumatology: Tofacitinib safety and dose-switching in RA The Immune-Mediated Inflammatory Disease Forum 7:32 2 years ago 172 Далее Скачать
Discussing Rheumatology: JAK Inhibitor Monotherapy in RA The Immune-Mediated Inflammatory Disease Forum 7:59 4 years ago 121 Далее Скачать
Trial results on upadacitinib for the treatment of RA | Roy Fleischmann Medicine Matters rheumatology 6:19 5 years ago 1 315 Далее Скачать
Long-term persistence and effectiveness of IL-12/23 pathway inhibitor ustekinumab and TNF inhibitors Annals of the Rheumatic Diseases 5:31 1 year ago 178 Далее Скачать
Rheumatology Author Professor Mease: Upadacitinib The Immune-Mediated Inflammatory Disease Forum 17:50 3 years ago 114 Далее Скачать
Dr Roy Fleischmann: ‘Long-term safety of sarilumab in rheumatoid arthritis' Oxford Academic (Oxford University Press) 4:13 4 years ago 1 562 Далее Скачать
